Pharmaceuticals

Biotech Ingredient Market Surges Amid Rising Demand In Personal Care Products Is Supporting Development Across The Biotech Ingredient Market

May 18, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Is The Market Value Of The Biotech Ingredient Market Projected To Expand During 2026–2030?

The biotech ingredient market has experienced robust growth in recent years. It is projected to expand from $63.25 billion in 2025 to $67.42 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 6.6%. This historical expansion can be attributed to factors such as a heightened demand for natural and safe ingredients, advancements in microbial fermentation technologies, increased awareness of biotech applications in food and personal care, a rising consumer preference for sustainable ingredients, and the early adoption of yeast- and algae-based compounds.

The biotech ingredient market is projected to experience substantial growth over the upcoming years. It is anticipated to reach $87.06 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.6%. This anticipated expansion is fueled by factors such as the widening scope of precision medicine and individualized nutrition, enhanced governmental backing for biotechnology research and development, the scaling up of microbial and yeast-based expression systems, the integration of artificial intelligence and automation in manufacturing processes, and its expanding utility across sectors like cosmetics, cleaning agents, and food production. Key developments expected during this timeframe encompass breakthroughs in synthetic biology, novel innovations in microbial engineering, the development of more economical methods for ingredient production, adherence to regulatory requirements and safety protocols, and further penetration into applications within the food, personal care, and cleaning product domains.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9817&type=smp

What Major Growth Factors Are Impacting The Biotech Ingredient Market?

The escalating demand for personal care products is anticipated to boost the growth of the biotech ingredient market moving forward. These products broadly cover items used for maintaining personal hygiene and improving one’s appearance. Biotech ingredients in personal care items provide advantages such as a diminished environmental footprint, sustainability, uniform quality, lower allergenic potential, biocompatibility, greater efficacy, and reduced reliance on petrochemicals. For example, in December 2024, the Bureau of Labor Statistics, a US-based government agency, reported that the average annual expenditure on personal care products and services increased from $866 per consumer unit in 2022 to $950 per consumer unit in 2023. Thus, the rising demand for personal care products is acting as a key driver for the expansion of the biotech ingredient market.

How Is The Biotech Ingredient Market Examined Through Segment Analysis?

The biotech ingredient market covered in this report is segmented –

1) By Type: Active Pharmaceutical Ingredients, Biosimilars

2) By Expression Systems: Mammalian Expression Systems, Microbial Expression Systems, Yeast Expression Systems, Plant Expression Systems, Insect Expression Systems

3) By Application: Food And Beverages, Personal Care And Cosmetics, Cleaning Products, Other Applications

Subsegments:

1) By Active Pharmaceutical Ingredients (APIs): Biologic APIs, Synthetic APIs

2) By Biosimilars: Monoclonal Antibodies, Recombinant Proteins, Insulin Biosimilars

Which Trends Are Affecting The Biotech Ingredient Market Framework?

Leading companies in the biotech ingredient market are concentrating on creating inventive solutions, like sophisticated biotechnology-derived ingredient platforms, to satisfy the increasing need for high-performing, sustainable, and cutting-edge cosmetic and personal care products. These ingredients, powered by biotechnology, utilize enzymatic and bio-based methods to form unique molecular structures that boast improved functionality, delivering superior performance, scalability, and ecological advantages over conventionally chemically synthesized ingredients. For example, in March 2023, International Flavors & Fragrances Inc., a US-based producer of fragrance, biotech solutions, cosmetic energetics, and organic health ingredients, introduced Aurist AGC, a new biopolymer designed for hair care. This demonstrates the new DEB platform’s capability, employing IFF’s extensive biotechnology expertise to provide durable and high-performing beauty solutions that can significantly drive innovation in the cosmeceutical sector. The ingredient incorporates IFF’s exclusive Designed Enzymatic Biopolymers (DEB) technology, an advanced biotechnological method able to generate new bio-based polysaccharides with unique structures and product characteristics.

Who Are The Prominent Players Across The Biotech Ingredient Market?

Major companies operating in the biotech ingredient market are Merck & Co. Inc., Sanofi S.A., AbbVie Inc., International Flavors & Fragrance (IFF) Inc., Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Mylan Inc., Boehringer Ingelheim International GmbH., AstraZeneca plc., Givaudan, Firmenich SA, Amyris Inc., Advanced BioTech, Sollice Biotech, Novocap S.A., Eli Lilly, Bristol-Myers Squibb Company, GlaxoSmithKline plc., F. Hoffmann-La Roche AG, Biogen Inc., Amgen Inc., Johnson & Johnson, Genentech Inc., Regeneron Pharmaceuticals Inc., Vertex Pharmaceuticals Incorporated, Alexion Pharmaceuticals Inc., Celgene Corporation, Gilead Sciences Inc., BioMarin Pharmaceutical Inc., Incyte Corporation, Seattle Genetics Inc., Alnylam Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Moderna Inc., Editas Medicine Inc., Intellia Therapeutics Inc., Sangamo Therapeutics Inc., Bluebird Bio Inc., Spark Therapeutics Inc.

Access The Complete Biotech Ingredient Market Report:

https://www.thebusinessresearchcompany.com/report/biotech-ingredient-global-market-report

Which Region Contributes The Most To The Biotech Ingredient Market?

Europe was the largest region in the biotech ingredient market in 2025. Asia-Pacific is expected to be the fastest-growing region in the biotech ingredients market report during the forecast period. The regions covered in the biotech ingredient market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Biotech Ingredient Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=9817&type=smp

Browse Through More Reports Similar to the Global Biotech Ingredient Market 2026, By The Business Research Company

Biotech Ingredient Market Report 2026

https://www.thebusinessresearchcompany.com/report/biotech-ingredient-global-market-report

Bioactive Ingredients Market Report 2026

https://www.thebusinessresearchcompany.com/report/bioactive-ingredients-global-market-report

Ingredients Market Report 2026

https://www.thebusinessresearchcompany.com/report/ingredients-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795